- Display 15 Products per page
Wound Care Market and Market Share Analysis (by Application [Skin Ulcer/Burns/Surgery] and by Product Category [Hydrocolloids, Adhesives, Pressure Relief, Silver Dressings, NPWT, Debridement, Collagen, Staples, Sutures and Other])Wound Care Market and Market Share Analysis (by Application [Skin Ulcer/Burns/Surgery] & by Product Category [Hydrocolloids, Adhesives, Pressure Relief, NPWT, Debridement, Staples, Sutures & Other])
Published: May 5, 2017 | Price: $2,800.00 – $5,600.00
There are dozens of significant competitors in advanced wound care and hundreds of smaller companies. Growth rates can be competitive in some segments and new entrants are constantly entering the market. Innovation is a must in the quest to reduce hospital stays and get patients back to full activity. This report, Advanced Wound Care Market Analysis, provides a company-focused, industry-driven look at the state of advanced wound care market. Figures in this report are entirely from real-world company financials...
Inherited Disease and Molecular Diagnostics Bundle 2017
Published: December 20, 2017 | Price: $2,640.00 – $5,280.00
Bundle of report sections including Molecular Assay Procedures Inherited Disease Markets Cancer Markers
Bundle: Medical Imaging Markets and Medical Contrast Agent Markets Global License
Published: September 27, 2012 | Price: $12,784.00
Kalorama's Medical Contrast Agents market research report and Molecular Imaging Report for global license in one bundled offering.
In Vitro Diagnostic (IVD) Test Markets in Brazil, Russia, India, China and Other Emerging Healthcare Systems
Published: June 1, 2011 | Price: $150.00 – $300.00
There is much discussion about emerging markets in in vitro diagnostics, especially the BRIC nations - Brazil, Russia, India and China. Which companies have been successful in these markets and how have they accomplished it? What kind of realistic growth can marketers expect by selling products in these areas? This report is intended to provide an overview of trends and developments in the IVD industry as it applies to emerging markets and the BRIC countries in particular. A Realistic Look...
Complex Regional Pain Syndrome (CRPS) – A Market Briefing
Published: August 1, 2005 | Price: $795.00 – $1,990.00
Neurological disease that impacts the sensory pathway can produce severe chronic pain, also known as neuropathic pain. This usually is unrelated to any peripheral tissue injury. This occurs with disorders of the central nervous system (CNS), such as stroke and multiple sclerosis, or with conditions associated with peripheral nerve damage, such as mechanical injury, diabetic neuropathy or herpes zoster infection. On form of neuropathic pain that is just now gaining recognistino is complex regional pain syndrome (CRPS), also known as...
World Market for Prescription Respiratory Drugs, The
Published: October 1, 2006 | Price: $3,500.00 – $7,000.00
The global market for prescription respiratory drugs encompasses a wide variety of products that treat both common everyday respiratory illnesses as well as serious chronic conditions such as COPD. Technological developments and improved delivery methods have given many health professionals a wider range of products to treat patients with respiratory diseases and have expanded the market for respiratory pharmaceuticals. This comprehensive study of the market for prescription pharmaceutical products to treat respiratory illness examines six distinct drug segments: Anti-inflammatories, Inhaled...
Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease
Published: December 1, 2003 | Price: $1,496.00 – $2,992.00
Severe Acute Respiratory Syndrome (SARS), which was a new and unidentified disease when it first affected people, ripped through Asia and Toronto from late 2002 into the summer of 2003, before being contained for the season. Taiwan with just 346 reported cases performed 10,000 diagnostic tests. Three years after West Nile Virus (WNV) first appeared in the United States in 1999 with just 62 cases and 7 deaths, the U.S. Center for Disease Control reports thousands of cases and 150...
The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Flow Cytometry)
Published: January 1, 2016 | Price: $2,396.00 – $4,792.00
The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Others) In Situ Hybridization, HPV Testing, Circulating Tumor Cells and Flow Cytometry are important histology and cytology approaches to testing. In situ hybridization and more specifically fluorescent in situ hybridization (FISH) techniques use DNA probes to detect pathogens and molecular structures in cells. More recently flow cytometry techniques and other cell capture devices allow lab professionals to select targeted cells that can be further analyzed with PCR, sequencing...
The World Market for Neurotherapeutic Drugs
Published: September 1, 2005 | Price: $3,500.00 – $7,000.00
Management of both acute and chronic neurologic diseases can be challenging for both the patient and the health care provider. Many neurologic disorders involve progressive deterioration in physical and mental capabilities, which can be devastating to the patient and the patient’s family. In many respects, neurotherapeutics represent the largest as-yet untapped market in medicine. This Kalorama Information report focuses on several key product segments of neurotherapeutic treatment: Alzheimer’s Disease and Other Dementias Brain and Neurologic Cancers Brain Trauma and Stroke...
The World Market for Respiratory Devices (Inhalers, Nebulizers, Airways, Masks, Sleep Apnea, Oxygen Therapy, Ventilators Medical Humidifiers, Respiratory Measurement)
Published: May 23, 2012 | Price: $2,500.00 – $5,000.00
The worldwide respiratory device market continues to grow despite economic downturns mainly due to the aging of the world population and increasing incidence of COPD. The market encompasses many different products to help treat and monitor respiratory conditions as well as many large and small manufacturers. Products included in the worldwide respiratory device market include: Inhalers Nebulizers Airway/Mask Equipment Sleep Apnea Equipment Oxygen therapy equipment and ventilators Medical Humidifiers Respiratory Measurement Devices The analysis presented in this report is based...
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition
Published: April 28, 2022 | Price: $6,000.00 – $12,000.00
As discussed in this report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition, POC testing has skyrocketed in the last 20 years as demand for accurate and rapid testing has blossomed both inside and outside the hospital setting. An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations...
Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)
Published: April 1, 2009 | Price: $500.00 – $3,990.00
Current economic conditions dominate business strategies. While healthcare has fared better than other industries, it will not be immune from the effects of the current recession. But what aspects of healthcare will be impacted? How much of spending will be out of the consumer's pocket? How will some novel trends (retail clinics, medical tourism) fit into this economy? It is commonly asserted that OTC and generic drugs sales will be boosted. Will this pan out? What will be the possible...
Emerging Infectious Disease Diagnostics: Markets and Trends
Published: May 27, 2020 | Price: $3,000.00 – $6,000.00
In light of the COVID-19 (coronavirus) pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away. Where could the next pandemic or epidemic come from? There are a number of diseases currently tracking as moving from the developed world to the developing world? Kalorama has addressed emerging infectious disease since our first study nine...
RFID in Pharmaceutical Manufacturing: Cost Saving Strategies for Pharmaceutical Companies and Opportunities for Technology Companies
Published: March 1, 2008 | Price: $995.00 – $3,990.00
Pharmaceutical manufacturers are utilizing new RIFD technologies to deal with multiple challenges they face in the manufacturing process. This Kalorama Information report discussions the solutions available, and covers the opportunities available to technology companies to provide services to this sector. Full coverage of the market for RFID technologies in pharmaceutical manufacturing operations is provided, including. Explanation of RFID Technologies Cost Savings from Implementation Total Market for RFID Technologies in Pharma Manufacturing Market Forecasts Major Companies Involved in RFID and...
Next Generation Sequencing (NGS) Markets 2015 (Systems, Consumables, Services, Acquisitions, Agreements, Competitive Analysis, Platforms, Applications, Brand Ownership and Other Trends)
Published: January 23, 2015 | Price: $995.00 – $7,000.00
Next Generation Sequencing (NGS) Markets 2015 (Systems, Consumables, Services, Acquisitions, Agreements, Competitive Analysis, Platforms, Applications, Brand Ownership and Other Trends) This report, Next-Generation Sequencing Markets (Systems, Consumables, Services, Acquisitions, Agreements, Competitive Analysis, Trends, Platforms, Applications, Brand Ownership) provides sizing and forecasts within this growing market. The first sequencing-based clinical diagnostic tests have been cleared by the FDA, and more will follow. Some next generation sequencing competitors developing kits that can be produced and sold to clinical laboratories following the standard...